SXTP60 DEGREES PHARMACEUTICALS, INC.vs its industry peers
A metric-by-metric comparison of 60 DEGREES PHARMACEUTICALS, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SXTPThis | $4M#12 | — | 0.9x#6 | 4.2x#2 | 65.5%#2 | 7.3%#9 | -771.6%#2 | -152.5%#6 | -167.4%#1 | 5#1 | -71.4%#6 | — |
| RNAZ | $5M#9 | — | 4.0x#10 | — | — | -106.9%#14 | — | -2769.7%#13 | — | — | -52.3%#3 | — |
| TRAW | $7M#5 | — | 0.6x#3 | 2.6x#1 | 1134.5%#1 | 105.5%#1 | -640.7%#1 | 79.2%#1 | — | — | -70.4%#5 | — |
| DRMA | $5M#10 | — | 0.7x#4 | — | — | 38.5%#5 | — | -117.9%#5 | — | — | -81.4%#9 | — |
| CNSP | $8M#4 | — | 119.9x#13 | — | — | -6.7%#10 | — | -22417.9%#14 | — | — | -24.2%#1 | — |
| RVPH | $5M#11 | — | 0.3x#1 | — | — | 33.6%#7 | — | -113.9%#4 | — | — | -96.2%#12 | — |
| ADIL | $7M#6 | — | 1.8x#9 | — | — | 39.6%#4 | — | -214.6%#7 | — | — | -73.8%#7 | — |
| TCRT | $45M#2 | — | 34.9x#12 | 8987.3x#5 | -50.0%#3 | 10.8%#8 | -84500.0%#5 | -324.2%#8 | — | — | -36.6%#2 | — |
| ACXP | $6M#7 | — | 0.9x#5 | — | — | 43.5%#2 | — | -113.6%#3 | — | — | -78.2%#8 | — |
| INDP | $194M#1 | — | 155.2x#14 | — | — | -38.8%#12 | — | -1670.8%#12 | — | — | -82.7%#10 | — |
| SNGX | $5M#8 | — | 1.7x#8 | 44.8x#3 | -85.8%#4 | -33.7%#11 | -9923.2%#3 | -359.2%#9 | — | 4#2 | -70.4%#4 | — |
| REVB | $4M#13 | — | 0.3x#2 | — | — | 40.7%#3 | — | -68.6%#2 | — | — | -90.1%#11 | — |
| HEPA | $9M#3 | 0.3x#1 | 5.0x#11 | — | — | 37.3%#6 | — | -445.8%#10 | — | — | — | — |
| JUNS | $3M#14 | — | — | 159.8x#4 | — | -254.4%#15 | -40873.2%#4 | — | — | — | — | — |
| FBLG | $3M#15 | 0.7x#2 | 1.3x#7 | — | — | -67.1%#13 | — | -717.2%#11 | -1413.3%#2 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-07-31.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice